XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenues and Trade Receivables, Net - Narrative (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Concentration Risk [Line Items]      
Current and non-current contract assets $ 601   $ 1,662
Contract liabilities 22,803   33,896
Capitalized contract cost, net 496   715
Contract and other receivables $ 1,668   $ 2,915
Maximum      
Concentration Risk [Line Items]      
Research and development, project duration 3 years    
Revenue from Contract with Customer Benchmark | Indivior | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk 54.00% 74.00%  
Revenue from Contract with Customer Benchmark | Hypera | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk   14.00%  
Revenue from Contract with Customer Benchmark | Hasico | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk 22.00%    
Revenue from Contract with Customer Benchmark | MTPA | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk 11.00%    
Receivables | Indivior | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk 58.00%   65.00%
Receivables | Hypera | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk 11.00%    
Receivables | Zevra | Customer concentration risk      
Concentration Risk [Line Items]      
Concentrations of risk     13.00%